Differences in activated clotting time among uninterrupted anticoagulants during the periprocedural period of atrial fibrillation ablation

Heart Rhythm

Volumn 12, Issue 9, 2015, Pages 1972-1978

  Nagao, Tomoyuki ^a   Inden, Yasuya ^a,b   Yanagisawa, Satoshi ^a   Kato, Hiroyuki ^a   Ishikawa, Shinji ^a   Okumura, Satoshi ^a   Mizutani, Yoshiaki ^a   Ito, Tadahiro ^a   Yamamoto, Toshihiko ^a   Yoshida, Naoki ^a   Hirai, Makoto ^b   Murohara, Toyoaki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

Author keywords

Activated clotting time; Atrial fibrillation; Catheter ablation; New oral anticoagulant

Indexed keywords

APIXABAN; DABIGATRAN; HEPARIN; RIVAROXABAN; WARFARIN; ANTICOAGULANT AGENT;

ABLATION THERAPY; ACTIVATED CLOTTING TIME; ADULT; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; ATRIAL FIBRILLATION; BLOOD CLOTTING TIME; BRAIN ISCHEMIA; CATHETER ABLATION; EVENING DOSAGE; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEART TAMPONADE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; PARTIAL THROMBOPLASTIN TIME; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PRIORITY JOURNAL; TRANSIENT ISCHEMIC ATTACK; BLOOD; BLOOD CLOTTING; COMPLICATION; DOSE RESPONSE; DRUG EFFECTS; INCIDENCE; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PERIOPERATIVE PERIOD; PROCEDURES; RETROSPECTIVE STUDY; THROMBOEMBOLISM;

ADMINISTRATION, ORAL; ANTICOAGULANTS; ATRIAL FIBRILLATION; BLOOD COAGULATION; CATHETER ABLATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PERIOPERATIVE CARE; RETROSPECTIVE STUDIES; THROMBOEMBOLISM;

EID: 84939639734     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2015.04.016     Document Type: Article

References (23)

1. T. Crawford, and H. Oral Current status and outcomes of catheter ablation for atrial fibrillation Heart Rhythm 6 suppl 2009 S12 S17
2. S.J. Connolly, M.D. Ezekowitz, S. Yusuf, et al. RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation [published correction appears in N Engl J Med 2010;363:1877] N Engl J Med 361 2009 1139 1151
3. M.R. Patel, K.W. Mahaffey, J. Garg, and et al. ROCKET-AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 2011 883 891
4. C.B. Granger, J.H. Alexander, J.J. McMurray, and et al. ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 2011 981 992
5. R. Providencia, J.P. Albenque, S. Combes, A. Bouzeman, B. Casteigt, N. Combes, K. Narayanan, E. Marijon, and S. Boveda Safety and efficacy of dabigatran versus warfarin in patients undergoing catheter ablation of atrial fibrillation: a systematic review and meta-analysis Heart 100 2014 324 335
6. A.A. Bin Abdulhak, A.R. Khan, I.M. Tleyjeh, J.A. Spertus, S.U. Sanders, K.E. Steigerwalt, M.A. Garbati, R.A. Bahmaid, and A.P. Wimmer Safety and efficacy of interrupted dabigatran for peri-procedural anticoagulation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis Europace 15 2013 1412 1420
7. M.R. Aryal, A. Ukaigwe, A. Pandit, P. Karmacharya, R. Pradhan, N.R. Mainali, R. Pathak, L. Jalota, Y. Bhandari, and A. Donato Meta-analysis of efficacy and safety of rivaroxaban compared with warfarin or dabigatran in patients undergoing catheter ablation for atrial fibrillation Am J Cardiol 114 2014 577 582
8. L. Di Biase, D. Burkhardt, P. Santangeli, and et al. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial Circulation 129 2014 2638 2644
9. F. Gaita, D. Caponi, M. Pianelli, M. Scaglione, E. Toso, F. Cesarani, C. Boffano, G. Gandini, M.C. Valentini, R. De Ponti, F. Halimi, and J.F. Leclercq Radiofrequency catheter ablation of atrial fibrillation: a cause of silent thromboembolism? Magnetic resonance imaging assessment of cerebral thromboembolism in patients undergoing ablation of atrial fibrillation Circulation 122 2010 1667 1673
10. M. Bassiouny, W. Saliba, J. Rickard, and et al. Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation [published correction appears in Circ Arrhythm Electrophysiol 2013;6:e79] Circ Arrhythm Electrophysiol 6 2013 460 466
11. S.V. Konduru, A.A. Cheema, P. Jones, Y. Li, B. Ramza, and A.P. Wimmer Differences in intraprocedural acts with standardized heparin dosing during catheter ablation for atrial fibrillation in patients treated with dabigatran vs. patients on uninterrupted warfarin J Interv Card Electrophysiol 35 2012 277 284
12. T. Yamaguchi Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperative Study Group. Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation: a multicenter, prospective, randomized trial Stroke 31 2000 817 821
13. F. Ouyang, D. Bansch, S. Ernst, A. Schaumann, H. Hachiya, M. Chen, J. Chun, P. Falk, A. Khanedani, M. Antz, and K.H. Kuck Complete isolation of left atrium surrounding the pulmonary veins: new insights from the double-Lasso technique in paroxysmal atrial fibrillation Circulation 110 2004 2090 2096
14. K. Nademanee, J. McKenzie, E. Kosar, M. Schwab, B. Sunsaneewitayakul, T. Vasavakul, C. Khunnawat, and T. Ngarmukos A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate J Am Coll Cardiol 43 2004 2044 2053
15. H. Oral, A. Chugh, E. Good, and et al. Radiofrequency catheter ablation of chronic atrial fibrillation guided by complex electrograms Circulation 115 2007 2606 2612
16. M. Haissaguerre, P. Sanders, M. Hocini, and et al. Catheter ablation of long-lasting persistent atrial fibrillation: critical structures for termination J Cardiovasc Electrophysiol 16 2005 1125 1137
17. H. Tada, H. Oral, C. Sticherling, S.P. Chough, R.L. Baker, K. Wasmer, F. Pelosi Jr, B.P. Knight, S.A. Strickberger, and F. Morady Double potentials along the ablation line as a guide to radiofrequency ablation of typical atrial flutter J Am Coll Cardiol 38 2001 750 755
18. S. Gautam, R.M. John, W.G. Stevenson, R. Jain, L.M. Epstein, U. Tedrow, B.A. Koplan, S. McClennen, and G.F. Michaud Effect of therapeutic INR on activated clotting times, heparin dosage, and bleeding risk during ablation of atrial fibrillation J Cardiovasc Electrophysiol 22 2011 248 254
19. L. Di Biase, J.D. Burkhardt, P. Mohanty, and et al. Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio Circulation 121 2010 2550 2556
20. A.A. Hussein, D.O. Martin, W. Saliba, and et al. Radiofrequency ablation of atrial fibrillation under therapeutic international normalized ratio: a safe and efficacious periprocedural anticoagulation strategy Heart Rhythm 6 2009 1425 1429
21. R. Providencia, J.P. Albenque, S. Combes, A. Bouzeman, B. Casteigt, N. Combes, K. Narayanan, E. Marijon, and S. Boveda Safety and efficacy of dabigatran versus warfarin in patients undergoing catheter ablation of atrial fibrillation: a systematic review and meta-analysis Heart 100 2014 324 335
22. H. Calkins, E.P. Gerstenfeld, R. Schilling, A. Verma, and S. Willems RE-CIRCUIT Study Steering Committee. RE-CIRCUIT study: Randomized Evaluation of Dabigatran Etexilate Compared to Warfarin in Pulmonary Vein Ablation: Assessment of an Uninterrupted Periprocedural Anticoagulation Strategy Am J Cardiol 115 2015 154 155
23. G.V. Naccarelli, R. Cappato, S.H. Hohnloser, F.E. Marchlinski, D.J. Wilber, J. Xiang, C. Ma, S. Hess, D.W. Davies, L.E. Fields, and A. Natale VENTURE-AF Investigators. Rationale and design of VENTURE-AF: a randomized, open-label, active-controlled multicenter study to evaluate the safety of rivaroxaban and vitamin K antagonists in subjects undergoing catheter ablation for atrial fibrillation J Interv Card Electrophysiol 41 2014 107 116